{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:22:11Z","timestamp":1760188931809},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2000,8,1]],"date-time":"2000-08-01T00:00:00Z","timestamp":965088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2000,8,1]],"date-time":"2000-08-01T00:00:00Z","timestamp":965088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2000,8]]},"DOI":"10.1007\/bf02780533","type":"journal-article","created":{"date-parts":[[2007,12,26]],"date-time":"2007-12-26T11:06:58Z","timestamp":1198667218000},"page":"225-228","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Retreatment with chimeric CD 20 monoclonal antibody in a patient with nodal marginal zone B-cell lymphoma"],"prefix":"10.1007","volume":"17","author":[{"given":"L-P","family":"Koh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L-C","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C-H","family":"Thng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2000,8,1]]},"reference":[{"key":"BF02780533_CR1","doi-asserted-by":"publisher","first-page":"2825","DOI":"10.1200\/JCO.1998.16.8.2825","volume":"8","author":"P McLaughlin","year":"1998","unstructured":"McLaughlin Pet al. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.J Clin Oncol 1998;8: 2825\u20132833.","journal-title":"J Clin Oncol"},{"key":"BF02780533_CR2","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1200\/JCO.1999.17.6.1851","volume":"6","author":"TA Davis","year":"1999","unstructured":"Davis TAet al. Single-agent monoclonal antibody efficacy in bulky non-Hodgkin's lymphoma: Results of a phase II trial of Rituximab.J Clin Oncol 1999;6: 1851\u20131857.","journal-title":"J Clin Oncol"},{"key":"BF02780533_CR3","doi-asserted-by":"publisher","first-page":"219","DOI":"10.7326\/0003-4819-76-2-219","volume":"76","author":"CM Bagley","year":"1972","unstructured":"Bagley CM Jr, Devita VT Jr, Berard CW, Canellos GP. Advanced lymphosarcoma: intensive cyclical combination chemotherapy with cyclophosphamide, vincritine and prednisolone.Ann Intern Med 1972;76: 219\u2013225.","journal-title":"Ann Intern Med"},{"key":"BF02780533_CR4","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1200\/JCO.1993.11.8.1573","volume":"8","author":"WH Wilson","year":"1993","unstructured":"Wilson WHet al. EPOCH chemotherapy: toxicity and efficacy in relapsed and refractory non-Hodgkin's lymphoma.J Clin Oncol 1993;8: 1573\u20131582.","journal-title":"J Clin Oncol"},{"key":"BF02780533_CR5","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1182\/blood.V60.3.693.693","volume":"60","author":"F Cabanillas","year":"1982","unstructured":"Cabanillas F, Hagemeister FB, Bodey GP, Freireich EJ. IMVP-16: an effective regimen for patients with lymphoma who relapsed after initial combination chemotherapy.Blood 1982;60: 693\u2013697.","journal-title":"Blood"},{"key":"BF02780533_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1182\/blood.V71.1.117.117","volume":"71","author":"WS Velasquez","year":"1988","unstructured":"Velasquez WSet al. Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP).Blood 1988;71 117\u2013122.","journal-title":"Blood"},{"key":"BF02780533_CR7","doi-asserted-by":"publisher","first-page":"3909","DOI":"10.1182\/blood.V89.11.3909","volume":"89","author":"International Lymphoma Study Group","year":"1997","unstructured":"International Lymphoma Study Group. The Non-Hodgkin's Lymphoma Project: A clinical evaluation of the International Lymphoma Study Group classification of the non-Hodgkin's lymphoma.Blood 1997;89: 3909\u20133818.","journal-title":"Blood"},{"key":"BF02780533_CR8","first-page":"128","volume":"36","author":"BN Nathwani","year":"1999","unstructured":"Nathwani BN, Drachenberg MR, Hernandez AM, Levine AM, Sheibani K. Nodal Monocytoid B-Cell Lymphoma (Nodal Marginal Zone B-Cell Lymphoma).Seminars in Haematology 1999;36: 128\u2013138.","journal-title":"Seminars in Haematology"},{"key":"BF02780533_CR9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s002770050419","volume":"77","author":"M Jensen","year":"1998","unstructured":"Jensen M, Winkler U, Manzke O, Diehl V, Engert A. Rapid tumour lysis in a patients with B-cell chronic lymphocytic leukemia and lymphocytosis treated with anit-CD20 monoclonal antibody (IDEC-C2B8, rituximab).Ann Hematol 1998;77: 89\u201391.","journal-title":"Ann Hematol"},{"key":"BF02780533_CR10","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1200\/JCO.1999.17.6.1962","volume":"17","author":"L-C Lim","year":"1999","unstructured":"Lim L-C, Koh L-P, Tan P. Fatal cytokine release syndrome with chimeric Anti-CD 20 monoclonal antibody Rituximab in a 71-year-old patient with chronic lymphocytic leukemia.J Clin Oncol 1999;17: 1962\u20131963.","journal-title":"J Clin Oncol"},{"key":"BF02780533_CR11","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1182\/blood.V94.7.2217.419k02_2217_2224","volume":"94","author":"U Winkler","year":"1999","unstructured":"Winkler Uet al. Cytokine-release syndrome in patients with B-cell chronic lymphocytic leukemia and high lymphocyte counts after treatment with an anti-CD 20 monoclonal antibody (Rituximab, IDEC-C2B8).Blood 1999;94: 2217\u20132224.","journal-title":"Blood"},{"key":"BF02780533_CR12","unstructured":"Davis Tet al. Retreatment with Rituximab have significant efficacy, do not cause HAMA, and are a viable minimally toxic alternative in relapsed or refractory non-Hodgkin's lymphoma (NHL). Presented at the 39th Annual Meeting of the American Society of Hematology December 5\u20139, 1997; San Diego, California."},{"key":"BF02780533_CR13","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1200\/JCO.1999.17.1.268","volume":"17","author":"MS Cruczman","year":"1999","unstructured":"Cruczman MSet al. Treatment of patients with low-grade B-cell lymphoma with the combination of anti-CD 20 monoclonal antibody and CHOP chemotherapy.J Clin Oncol 1999;17: 268\u2013276.","journal-title":"J Clin Oncol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02780533.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF02780533\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02780533","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02780533.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T02:16:56Z","timestamp":1702606616000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF02780533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,8]]}},"alternative-id":["BF02780533"],"URL":"https:\/\/doi.org\/10.1007\/bf02780533","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,8]]},"assertion":[{"value":"17 December 1999","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 1999","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2000","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}